Companies: 10,795·Total market cap: $144.5T

Universal Ibogaine Inc.

Universal Ibogaine Inc.

IBOGFOTCHealthcare● Active

$0.01

$-0.02(-52.95%)

Market Cap$4622485

P/E Ratio—

52W High$0.35

52W Low$0.0023

Avg Volume1.4M

Open$0.03

Beta4.37

Net Income Financials Revenue

Universal Ibogaine Inc. (IBOGF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

IBOGF · net income · updated Jun 15, 2026

Core profitability metrics

IBOGF · net income · margin · TTM · CAGR

Net income was −$10.5M for FY2022 (fiscal year ending 2022-07-31), down 171.4% year-over-year. Net profit margin was -980.2%.

FY2022 Net Income−$10.5M▼ -171.4% YoY

Trailing 12M (TTM)−$1.7Mtrailing 4 quarters sum

Net Profit Margin-980.2%−$10.5M ÷ $1.1M

YoY Change-171.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · IBOGF net income history · IBOGF profit margin

Annual net income data

IBOGF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2022Loss−$10.5M▼ 171.4%-980.2%$1.1M

FY2021Loss−$3.9M▼ 3168.7%—$0

FY2020Loss−$118,309▼ 20.6%—$0

FY2019Loss−$98,109▲ +76.0%—$0

FY2018Loss−$408,289——$0

Net income vs peers (Healthcare)

IBOGF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Universal Ibogaine Inc.YOU

IBOGF

−$10.5M-171.4%-980.2%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Universal Ibogaine Inc. (IBOGF) reported net income of −$10.5M for FY2022 (fiscal year ending 2022-07-31), down 171.4% year-over-year. The net profit margin was -980.2% — meaning the company kept $-9.80 of every dollar of revenue as profit.

Universal Ibogaine Inc. has not yet achieved annual profitability based on available data (5 fiscal years). The company has reported net losses across all available periods.

Universal Ibogaine Inc.'s net profit margin was -980.2% for FY2022, based on the latest annual results.

Investors sometimes search for "Universal Ibogaine Inc. net worth" — the company's market capitalization is a separate figure from IBOGF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

IBOGF net income · 4 questions

Universal Ibogaine Inc. is not currently profitable on an annual basis. The company reported a net loss of $10.5M for FY2022.

is IBOGF profitabledoes IBOGF make a profitIBOGF profitabilityIBOGF profitable company

▸ Source: FMP /income-statement · GAAP · Universal Ibogaine Inc. · Universal Ibogaine Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026